Adem ÖZKARA, Atilla İLHAN, Burcu YANIK, M. Ramazan YİĞİTOĞLU, Erkan KIBRISLI, İrfan ŞENCAN, Oğuz TEKİN, Metin CANBAL

Effects of plasma lipids and smoking on cognitive function

To research the relations between plasma lipids and smoking as they affect cognitive functions. Some studies have suggested a relationship between plasma cholesterol concentration, smoking, and the frequency of cognitive disturbances. Our hypothesis was that plasma lipids and smoking are related to cognitive impairment. Materials and methods: The plasma lipid profiles and cognitive functions of the subjects were measured and the relations among plasma lipid levels, smoking, and cognitive functions were observed. The study was performed on subjects with no history of chronic disease. Mental status was evaluated by the mini-mental state examination (MMSE) in patients over 40 years of age at the Family Medicine Clinic. In the statistical analyses, Mann-Whitney U, logistic regression, Pearson correlation, and factorial ANOVA tests were used. Results: Increased total cholesterol (TC), low-density lipoprotein (LDL), very low-density lipoprotein (VLDL), and low-density to high-density lipid ratios (LDL/HDL) were associated with reduced mental test scores, while high-density lipoprotein (HDL) levels were correlated with improved cognitive function. The negative relation between LDL and cognitive function was more relevant in smokers. Age was negatively related in both genders, whereas educational status was positively related, particularly in women. There was a negative correlation between LDL and language scores on the MMSE and this relation was more relevant in smokers. The mean LDL and LDL/HDL scores of the “24 points and lower” group for total MMSE scores were statistically higher than those of the “over 24” group. Conclusion: We concluded that for individuals with higher TC, VLDL, LDL, and LDL/HDL ratio levels and/or lower HDL levels, mental functions should be followed carefully, especially in smokers.

Anahtar Kelimeler:

Key words: Smoking, cognitive function, low-density lipoprotein, high-density lipoprotein, mental status

Effects of plasma lipids and smoking on cognitive function

Keywords:

Key words: Smoking, cognitive function, low-density lipoprotein, high-density lipoprotein, mental status,

PDF

___

Tipper SP. Attention and action. In: Gazzaniga MS, editor. The Cognitive Neurosciences. 3rd ed. Cambridge: MIT Press; 2004. p.634. 6. Shapiro K, Caramazza A. The organization of lexical knowledge in the brain: The grammatical dimension. In: Gazzaniga MS, editor. The Cognitive Neurosciences. 3rd ed. Cambridge: MIT Press; 2004. p.803-804.
Granholm AC, Bimonte-Nelson HA, Moore AB, Nelson ME, Freeman LR, Sambamurti K. Effects of a saturated fat and high cholesterol diet on memory and hippocampal morphology in the middle-aged rat. J Alzheimers Dis 2008; 14: 133-45.
Zhang J, McKeown RE, Hajjar I. Serum cholesterol levels are associated with impaired recall memory among older people. Age Ageing 2005; 34: 178-82. 9. Zhao S, Liao W, Xu N, Xu H, Yu C, Liu X, Li C. Polar metabolite of cholesterol induces rat cognitive dysfunctions. Neuroscience 2009; 164: 398-403.
Van den Kommer TN, Dik MG, Comijs HC, Fassbender K, Lütjohann D, Jonker C. Total cholesterol and oxysterols: early markers for cognitive decline in elderly? Neurobiol Aging 2009; 30: 534-45.
Gatto NM, Henderson VW, St. John JA, McCleary C, Hodis HN, Mack WJ. Metabolic syndrome and cognitive function in healthy middle-aged and older adults without diabetes. Neuropsychol Dev Cogn B Aging Neuropsychol Cogn 2008; 15: 627-41.
Nau JY. Hdl-cholesterol, protective role from amnesia. Rev Med Suisse 2008; 16: 1685.
Singh-Manoux A, Gimeno D, Kivimaki M, Brunner E, Marmot MG. Low HDL cholesterol is a risk factor for deficit and decline in memory in midlife: the Whitehall II study. Arterioscler Thromb Vasc Biol 2008; 28: 1556-62.
Greenstein JE, Kassel JD. The effects of smoking and smoking abstinence on verbal and visuospatial working memory capacity. Exp Clin Psychopharmacol 2009; 17: 78-90.
Hemmingsson T, Kriebel D, Tynelius P, Rasmussen F, Lundberg I. Adolescent mental health predicts quitting smoking in adulthood: a longitudinal analysis. Eur J Public Health 2008; 18: 66-70.
Heiligenstein E, Smith SS. Smoking and mental health problems in treatment-seeking university students. Nicotine Tob Res 2006; 8: 519-23.
Santacruz KS, Swagerty D. Early diagnosis of dementia. Am Fam Physician 2001; 63: 703-13, 717-8.
Tschanz JT, Corcoran C, Skoog I, Khachaturian AS, Herrick J, Hayden KM et al. Dementia: the leading predictor of death in a defined elderly population: the Cache County Study. Neurology 2004; 62: 1156-62.
Gürvit HI. Demans sendromu, Alzheimer hastalığı ve Alzheimer dışı demanslar. In: Bahar SZ, Öge AE, editors. Nöroloji. 1st ed. İstanbul: Nobel Tıp Kitabevleri; 2004. p.367- 415.
Hebert LE, Scherr PA, Beckett LA, Albert MS, Pilgrim DM, Chown MJ et al. Age-specific incidence of Alzheimer’s disease in a community population. JAMA 1995; 273: 1354-9.
Gürvit H, Emre M, Tinaz S, Bilgiç B, Hanagasi H, Şahin H et al. The prevalence of dementia in an urban Turkish population. Am J Alzheimers Dis Other Demen 2008; 23: 67-76.
Jack CR Jr, Knopman DS, Jagust WJ, Shaw LM, Aisen PS, Weiner MW, Petersen RC, Trojanowski JQ. Hypothetical model of dynamic biomarkers of the Alzheimer’s pathological cascade. Lancet Neurol 2010; 9: 119-28.
Martins IJ, Berger T, Sharman MJ, Verdile G, Fuller SJ, Martins RN. Cholesterol metabolism and transport in the pathogenesis of Alzheimer’s disease. J Neurochem 2009; 111: 1275-308.
Simons M, Keller P, Dichgans J, Schulz JB. Cholesterol and Alzheimer’s disease: is there a link? Neurology 2001; 57: 1089- 93.
Pappolla MA, Bryant-Thomas TK, Herbert D, Pacheco J, Fabra Garcia M, Manjon M et al. Mild hypercholesterolemia is an early risk factor for the development of Alzheimer amyloid pathology. Neurology 2003; 61: 199-205.
Pappolla MA, Smith MA, Bryant-Thomas T, Bazan N, Petanceska S, Perry G et al. Cholesterol, oxidative stress, and Alzheimer’s disease: expanding the horizons of pathogenesis. Free Radic Biol Med 2002; 33: 173-81.
Haley RW, Dietschy JM. Is there a connection between the concentration of cholesterol circulating in plasma and the rate of neuritic formation in Alzheimer disease? Arch Neurol 2000; 57: 1439-43.
Sabbagh M, Zahiri HR, Ceimo J, Cooper K, Gaul W, Connor D et al. Is there a characteristic lipid profile in Alzheimer’s disease? J Alzheimers Dis 2004; 6: 585-9.
Folstein MF, Folstein S, McHugh PR. Mini-mental state: A practical method for grading the cognitive state of patient for clinician. Journal of Psychiatric Research 1975; 12: 189-198.
Ivnik RJ, Smith GE, Cerhan JH, Boeve BF, Tangalos EG, Petersen RC. Understanding the diagnostic capabilities of cognitive tests. Clin Neuropsychol 2001; 15: 114-24.
Tangalos EG, Smith GE, Ivnik RJ, Petersen RC, Kokmen E, Kurland LT et al. The mini-mental state examination in general medical practice: clinical utility and acceptance. Mayo Clin Proc 1996; 71: 829-37.
Molloy DW, Standish TIM. A guide to the standardized mini- mental state examination. International Psychogeriatrics 1997; 9: 87-94.
Güngen C, Ertan T, Eker E, Yaşar R, Engin F. Standardize Mini Mental Test’in Türk toplumunda hafif demans tanısında geçerlik ve güvenirliği. Türk Psikiyatri Dergisi 2002; 13: 273- 281.
Zhang X, Li C, Zhang M. Psychosocial risk factors of Alzheimer’s disease. Zhonghua Yi Xue Za Zhi 1999; 79: 335-8.